Access cutting-edge geographic atrophy treatment through this clinical trial at a research site in Mountain View. Study-provided care at no cost to qualified participants.
Access geographic atrophy specialists in Mountain View at no cost
This study follows strict safety protocols and ethical guidelines
All study-related geographic atrophy treatment provided free
The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-related macular degeneration (AMD).
Sponsor: Annexon, Inc.
Check if you qualify for this geographic atrophy clinical trial in Mountain View, CA
If you're searching for geographic atrophy treatment options in Mountain View, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mountain View research site is actively enrolling participants for this clinical trial. You'll receive care from experienced geographic atrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.